According to the EMAs Pharmacovigilance Risk Assessment Committee, NAION will be listed as a rare side effect, meaning it may occur in up to 1 in 10,000 patients after a year or more of treatment
This drug Semaglutide can help them lose weight however it doesnt prevent obesity and should be taken under supervision of a healthcare professional
They are prepared by licensed compounding pharmacies to meet individual patient needs when commercially available options are not suitable for their personalized needs
As a glucagon-like peptide-1 (GLP-1) receptor agonist, semaglutide works by mimicking the effects of the GLP-1 hormone, which regulates appetite and food intake
For many, semaglutide has been a reliable choice, but with new options available, you might be contemplating switching from semaglutide to tirzepatide to enhance your health outcomes